These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 17724373
1. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells. Chintharlapalli S, Papineni S, Liu S, Jutooru I, Chadalapaka G, Cho SD, Murthy RS, You Y, Safe S. Carcinogenesis; 2007 Nov; 28(11):2337-46. PubMed ID: 17724373 [Abstract] [Full Text] [Related]
2. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways. Chintharlapalli S, Papineni S, Konopleva M, Andreef M, Samudio I, Safe S. Mol Pharmacol; 2005 Jul; 68(1):119-28. PubMed ID: 15798084 [Abstract] [Full Text] [Related]
3. Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells. Papineni S, Chintharlapalli S, Safe S. Mol Pharmacol; 2008 Feb; 73(2):553-65. PubMed ID: 17989348 [Abstract] [Full Text] [Related]
4. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1. Chintharlapalli S, Papineni S, Baek SJ, Liu S, Safe S. Mol Pharmacol; 2005 Dec; 68(6):1782-92. PubMed ID: 16155208 [Abstract] [Full Text] [Related]
5. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells. Chintharlapalli S, Papineni S, Jutooru I, McAlees A, Safe S. Mol Cancer Ther; 2007 May; 6(5):1588-98. PubMed ID: 17513608 [Abstract] [Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma J, Zou B, Gu Q, Wang J, Pang R, Lan HY, Wong BC. Cancer Res; 2009 Jun 01; 69(11):4776-83. PubMed ID: 19458067 [Abstract] [Full Text] [Related]
7. Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists. Kassouf W, Chintharlapalli S, Abdelrahim M, Nelkin G, Safe S, Kamat AM. Cancer Res; 2006 Jan 01; 66(1):412-8. PubMed ID: 16397256 [Abstract] [Full Text] [Related]
8. Rhodanine derivatives as novel peroxisome proliferator-activated receptor gamma agonists. Liu Q, Zhang YY, Lu HL, Li QY, Zhou CH, Wang MW. Acta Pharmacol Sin; 2007 Dec 01; 28(12):2033-9. PubMed ID: 18031620 [Abstract] [Full Text] [Related]
14. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ). Tan BS, Kang O, Mai CW, Tiong KH, Khoo AS, Pichika MR, Bradshaw TD, Leong CO. Cancer Lett; 2013 Aug 09; 336(1):127-39. PubMed ID: 23612072 [Abstract] [Full Text] [Related]
15. Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma. Au-Yeung KK, Liu PL, Chan C, Wu WY, Lee SS, Ko JK. Cancer Invest; 2008 Aug 09; 26(7):708-17. PubMed ID: 18608213 [Abstract] [Full Text] [Related]
17. Mycophenolic acid as a latent agonist of PPARgamma. Ubukata M, Takamori H, Ohashi M, Mitsuhashi S, Yamashita K, Asada T, Nakajima N, Matsuura N, Tsuruga M, Taki K, Magae J. Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4767-70. PubMed ID: 17618115 [Abstract] [Full Text] [Related]
19. Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells. Sun WH, Chen GS, Ou XL, Yang Y, Luo C, Zhang Y, Shao Y, Xu HC, Xiao B, Xue YP, Zhou SM, Zhao QS, Ding GX. Cancer Lett; 2009 Mar 18; 275(2):247-55. PubMed ID: 19056168 [Abstract] [Full Text] [Related]